Profile: Microbia, Inc. develops and markets pharmaceuticals for the healthcare industry. We focus on testing the gastrointestinal and cholesterol-busting drug candidates in their pipeline. We develop our drug candidate linaclotide, which is undergoing trials for the treatment of irritable bowel syndrome and chronic constipation.